2019冠狀病毒病藥物研發 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "2019冠狀病毒病藥物研發" in Chinese language version.

refsWebsite

Global rank Chinese rank

13web.archive.org

1^st place

8doi.org

2^nd place

23^rd place

7nih.gov

4^th place

5^th place

2europa.eu

68^th place

209^th place

2fda.gov

447^th place

581^st place

1biorender.com

low place

1science.org

1,160^th place

1,594^th place

1semanticscholar.org

11^th place

332^nd place

1clinicaltrialsarena.com

low place

1bloomberg.com

99^th place

225^th place

1statnews.com

8,771^st place

9,752^nd place

1scmp.com

362^nd place

236^th place

1jst.go.jp

1,903^rd place

1,240^th place

1airtable.com

low place

1reuters.com

49^th place

81^st place

airtable.com (Global: low place; Chinese: low place)

COVID-19 vaccine and treatments tracker (Choose vaccines or treatments tab, apply filters to view select data). Milken Institute. 21 June 2021 [11 June 2021]. （原始内容存档于24 June 2021）.

biorender.com (Global: low place; Chinese: low place)

COVID-19 vaccine and therapeutics tracker. BioRender. 5 April 2021 [21 June 2021]. （原始内容存档于2020-10-03）.

bloomberg.com (Global: 99^th place; Chinese: 225^th place)

Chinese Vaccine Approved for Human Testing at Virus Epicenter. Bloomberg News. 19 March 2020 [21 March 2020]. （原始内容存档于21 March 2020）.

clinicaltrialsarena.com (Global: low place; Chinese: low place)

China approves first anti-viral drug against coronavirus Covid-19. Clinical Trials Arena. 18 February 2020 [21 March 2020]. （原始内容存档于21 March 2020）.

doi.org (Global: 2^nd place; Chinese: 23^rd place)

Kupferschmidt K, Cohen J. WHO launches global megatrial of the four most promising coronavirus treatments. Science Magazine. 22 March 2020 [27 March 2020]. S2CID 216325781. doi:10.1126/science.abb8497. （原始内容存档于14 September 2020）.
Dhama K, Sharun K, Tiwari R, Dadar M, Malik YS, Singh KP, Chaicumpa W. COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Human Vaccines & Immunotherapeutics. June 2020, 16 (6): 1232–1238. PMC 7103671 . PMID 32186952. doi:10.1080/21645515.2020.1735227 .
Zhang L, Liu Y. Potential interventions for novel coronavirus in China: A systematic review. Journal of Medical Virology. May 2020, 92 (5): 479–490. PMC 7166986 . PMID 32052466. doi:10.1002/jmv.25707 .
COVID-19 Clinical Research Coalition. Global coalition to accelerate COVID-19 clinical research in resource-limited settings. Lancet. April 2020, 395 (10233): 1322–1325. PMC 7270833 . PMID 32247324. doi:10.1016/s0140-6736(20)30798-4 .
Maguire BJ, Guérin PJ. A living systematic review protocol for COVID-19 clinical trial registrations. Wellcome Open Research. 2 April 2020, 5: 60. PMC 7141164 . PMID 32292826. doi:10.12688/wellcomeopenres.15821.1 .
Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nature Reviews. Drug Discovery. March 2020, 19 (3): 149–150. PMID 32127666. doi:10.1038/d41573-020-00016-0 .
Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discoveries & Therapeutics. 29 February 2020, 14 (1): 58–60 [21 March 2020]. PMID 32147628. doi:10.5582/ddt.2020.01012 . （原始内容存档于20 March 2020）.
Harrison C. Coronavirus puts drug repurposing on the fast track. Nature Biotechnology. April 2020, 38 (4): 379–381. PMID 32205870. doi:10.1038/d41587-020-00003-1 .

europa.eu (Global: 68^th place; Chinese: 209^th place)

ema.europa.eu

First regulatory workshop on COVID-19 facilitates global collaboration on vaccine development. European Medicines Agency. 18 March 2020 [21 March 2020]. （原始内容存档于20 March 2020）.
Call to pool research resources into large multi-centre, multi-arm clinical trials to generate sound evidence on COVID-19 treatments. European Medicines Agency. 19 March 2020 [21 March 2020]. （原始内容存档于21 March 2020）.

fda.gov (Global: 447^th place; Chinese: 581^st place)

Coronavirus (COVID-19) Update: FDA Continues to Facilitate Development of Treatments (新闻稿). U.S. Food and Drug Administration (FDA). 19 March 2020 [21 March 2020]. （原始内容存档于20 March 2020）.
The Drug Development Process. U.S. Food and Drug Administration (FDA). 4 January 2018 [21 March 2020]. （原始内容存档于22 February 2020）.

jst.go.jp (Global: 1,903^rd place; Chinese: 1,240^th place)

jstage.jst.go.jp

Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discoveries & Therapeutics. 29 February 2020, 14 (1): 58–60 [21 March 2020]. PMID 32147628. doi:10.5582/ddt.2020.01012 . （原始内容存档于20 March 2020）.

nih.gov (Global: 4^th place; Chinese: 5^th place)

ncbi.nlm.nih.gov

Dhama K, Sharun K, Tiwari R, Dadar M, Malik YS, Singh KP, Chaicumpa W. COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Human Vaccines & Immunotherapeutics. June 2020, 16 (6): 1232–1238. PMC 7103671 . PMID 32186952. doi:10.1080/21645515.2020.1735227 .
Zhang L, Liu Y. Potential interventions for novel coronavirus in China: A systematic review. Journal of Medical Virology. May 2020, 92 (5): 479–490. PMC 7166986 . PMID 32052466. doi:10.1002/jmv.25707 .
COVID-19 Clinical Research Coalition. Global coalition to accelerate COVID-19 clinical research in resource-limited settings. Lancet. April 2020, 395 (10233): 1322–1325. PMC 7270833 . PMID 32247324. doi:10.1016/s0140-6736(20)30798-4 .
Maguire BJ, Guérin PJ. A living systematic review protocol for COVID-19 clinical trial registrations. Wellcome Open Research. 2 April 2020, 5: 60. PMC 7141164 . PMID 32292826. doi:10.12688/wellcomeopenres.15821.1 .
Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nature Reviews. Drug Discovery. March 2020, 19 (3): 149–150. PMID 32127666. doi:10.1038/d41573-020-00016-0 .
Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discoveries & Therapeutics. 29 February 2020, 14 (1): 58–60 [21 March 2020]. PMID 32147628. doi:10.5582/ddt.2020.01012 . （原始内容存档于20 March 2020）.
Harrison C. Coronavirus puts drug repurposing on the fast track. Nature Biotechnology. April 2020, 38 (4): 379–381. PMID 32205870. doi:10.1038/d41587-020-00003-1 .

reuters.com (Global: 49^th place; Chinese: 81^st place)

Beasley, Deena. COVID-19 pill developers aim to top Merck, Pfizer efforts. Reuters (Reuters). 28 September 2021 [4 October 2021]. （原始内容存档于4 October 2021）（英语）.

science.org (Global: 1,160^th place; Chinese: 1,594^th place)

Kupferschmidt K, Cohen J. WHO launches global megatrial of the four most promising coronavirus treatments. Science Magazine. 22 March 2020 [27 March 2020]. S2CID 216325781. doi:10.1126/science.abb8497. （原始内容存档于14 September 2020）.

scmp.com (Global: 362^nd place; Chinese: 236^th place)

Chan M. Chinese military scientists ordered to win global race to develop coronavirus vaccine. South China Morning Post. 19 March 2020 [22 March 2020]. （原始内容存档于22 March 2020）.

semanticscholar.org (Global: 11^th place; Chinese: 332^nd place)

api.semanticscholar.org

Kupferschmidt K, Cohen J. WHO launches global megatrial of the four most promising coronavirus treatments. Science Magazine. 22 March 2020 [27 March 2020]. S2CID 216325781. doi:10.1126/science.abb8497. （原始内容存档于14 September 2020）.

statnews.com (Global: 8,771^st place; Chinese: 9,752^nd place)

Fox M. Drug makers are racing to develop immune therapies for Covid-19. Will they be ready in time?. Stat. 19 March 2020 [21 March 2020]. （原始内容存档于22 March 2020）.

web.archive.org (Global: 1^st place; Chinese: 1^st place)

COVID-19 vaccine and therapeutics tracker. BioRender. 5 April 2021 [21 June 2021]. （原始内容存档于2020-10-03）.
Kupferschmidt K, Cohen J. WHO launches global megatrial of the four most promising coronavirus treatments. Science Magazine. 22 March 2020 [27 March 2020]. S2CID 216325781. doi:10.1126/science.abb8497. （原始内容存档于14 September 2020）.
First regulatory workshop on COVID-19 facilitates global collaboration on vaccine development. European Medicines Agency. 18 March 2020 [21 March 2020]. （原始内容存档于20 March 2020）.
Coronavirus (COVID-19) Update: FDA Continues to Facilitate Development of Treatments (新闻稿). U.S. Food and Drug Administration (FDA). 19 March 2020 [21 March 2020]. （原始内容存档于20 March 2020）.
China approves first anti-viral drug against coronavirus Covid-19. Clinical Trials Arena. 18 February 2020 [21 March 2020]. （原始内容存档于21 March 2020）.
Chinese Vaccine Approved for Human Testing at Virus Epicenter. Bloomberg News. 19 March 2020 [21 March 2020]. （原始内容存档于21 March 2020）.
Fox M. Drug makers are racing to develop immune therapies for Covid-19. Will they be ready in time?. Stat. 19 March 2020 [21 March 2020]. （原始内容存档于22 March 2020）.
Chan M. Chinese military scientists ordered to win global race to develop coronavirus vaccine. South China Morning Post. 19 March 2020 [22 March 2020]. （原始内容存档于22 March 2020）.
Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discoveries & Therapeutics. 29 February 2020, 14 (1): 58–60 [21 March 2020]. PMID 32147628. doi:10.5582/ddt.2020.01012 . （原始内容存档于20 March 2020）.
The Drug Development Process. U.S. Food and Drug Administration (FDA). 4 January 2018 [21 March 2020]. （原始内容存档于22 February 2020）.
Call to pool research resources into large multi-centre, multi-arm clinical trials to generate sound evidence on COVID-19 treatments. European Medicines Agency. 19 March 2020 [21 March 2020]. （原始内容存档于21 March 2020）.
COVID-19 vaccine and treatments tracker (Choose vaccines or treatments tab, apply filters to view select data). Milken Institute. 21 June 2021 [11 June 2021]. （原始内容存档于24 June 2021）.
Beasley, Deena. COVID-19 pill developers aim to top Merck, Pfizer efforts. Reuters (Reuters). 28 September 2021 [4 October 2021]. （原始内容存档于4 October 2021）（英语）.

2019冠狀病毒病藥物研發 (Chinese Wikipedia)

airtable.com (Global: low place; Chinese: low place)

biorender.com (Global: low place; Chinese: low place)

bloomberg.com (Global: 99th place; Chinese: 225th place)

clinicaltrialsarena.com (Global: low place; Chinese: low place)

doi.org (Global: 2nd place; Chinese: 23rd place)

europa.eu (Global: 68th place; Chinese: 209th place)

ema.europa.eu

fda.gov (Global: 447th place; Chinese: 581st place)

jst.go.jp (Global: 1,903rd place; Chinese: 1,240th place)

jstage.jst.go.jp

nih.gov (Global: 4th place; Chinese: 5th place)

ncbi.nlm.nih.gov

reuters.com (Global: 49th place; Chinese: 81st place)

science.org (Global: 1,160th place; Chinese: 1,594th place)

scmp.com (Global: 362nd place; Chinese: 236th place)

semanticscholar.org (Global: 11th place; Chinese: 332nd place)

api.semanticscholar.org

statnews.com (Global: 8,771st place; Chinese: 9,752nd place)

web.archive.org (Global: 1st place; Chinese: 1st place)

bloomberg.com (Global: 99^th place; Chinese: 225^th place)

doi.org (Global: 2^nd place; Chinese: 23^rd place)

europa.eu (Global: 68^th place; Chinese: 209^th place)

fda.gov (Global: 447^th place; Chinese: 581^st place)

jst.go.jp (Global: 1,903^rd place; Chinese: 1,240^th place)

nih.gov (Global: 4^th place; Chinese: 5^th place)

reuters.com (Global: 49^th place; Chinese: 81^st place)

science.org (Global: 1,160^th place; Chinese: 1,594^th place)

scmp.com (Global: 362^nd place; Chinese: 236^th place)

semanticscholar.org (Global: 11^th place; Chinese: 332^nd place)

statnews.com (Global: 8,771^st place; Chinese: 9,752^nd place)

web.archive.org (Global: 1^st place; Chinese: 1^st place)